X-doc.ai Information

X-doc.ai, developed by Deep Intelligent Pharma (DIP), is a revolutionary AI-powered platform redefining how industries approach document translation. Trusted by over 1,000 leading organizations—including pharmaceutical giants like Bayer, Bristol Myers Squibb, and Johnson & Johnson, as well as top research institutions like Kobe University—X-doc.ai delivers unmatched accuracy and scalability in translation workflows. Built with industry-specific intelligence, X-doc.ai achieves an industry-leading 99% accuracy rate, even for complex, technical content. Whether you're a translation agency managing bulk projects, a medical firm handling clinical trials, a legal team working on regulatory compliance, or a financial analyst translating market research, X-doc.ai ensures your documents are precise, consistent, and compliant. Backed by powerhouse investors like Sequoia, and equipped with enterprise-grade security (SOC2, ISO27001), X-doc.ai supports batch processing, long document handling, OCR for image-based text, and manual typesetting—making it the go-to solution for high-stakes translation needs across global industries.